231 related articles for article (PubMed ID: 24066967)
41. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
42. The intracellular localization of deoxycytidine kinase.
Hatzis P; Al-Madhoon AS; Jüllig M; Petrakis TG; Eriksson S; Talianidis I
J Biol Chem; 1998 Nov; 273(46):30239-43. PubMed ID: 9804782
[TBL] [Abstract][Full Text] [Related]
43. Novel PET probes specific for deoxycytidine kinase.
Shu CJ; Campbell DO; Lee JT; Tran AQ; Wengrod JC; Witte ON; Phelps ME; Satyamurthy N; Czernin J; Radu CG
J Nucl Med; 2010 Jul; 51(7):1092-8. PubMed ID: 20554721
[TBL] [Abstract][Full Text] [Related]
44. Quantitative immunoassay of human deoxycytidine kinase in malignant cells.
Kawasaki H; Carrera CJ; Carson DA
Anal Biochem; 1992 Nov; 207(1):193-6. PubMed ID: 1489095
[TBL] [Abstract][Full Text] [Related]
45. Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells.
Veuger MJ; Heemskerk MH; Honders MW; Willemze R; Barge RM
Blood; 2002 Feb; 99(4):1373-80. PubMed ID: 11830489
[TBL] [Abstract][Full Text] [Related]
46. Targeted Delivery of Deoxycytidine Kinase to Her2-Positive Cells Enhances the Efficacy of the Nucleoside Analog Fludarabine.
Koduvayur SP; Su Y; Kay BK; Lavie A
PLoS One; 2016; 11(6):e0157114. PubMed ID: 27280468
[TBL] [Abstract][Full Text] [Related]
47. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
[TBL] [Abstract][Full Text] [Related]
48. Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining.
Keszler G; Spasokoukotskaja T; Csapo Z; Talianidis I; Eriksson S; Staub M; Sasvari-Szekely M
Biochem Pharmacol; 2004 Mar; 67(5):947-55. PubMed ID: 15104248
[TBL] [Abstract][Full Text] [Related]
49. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
Zhu C; Johansson M; Permert J; Karlsson A
Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
[TBL] [Abstract][Full Text] [Related]
50. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
51. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
[TBL] [Abstract][Full Text] [Related]
52. Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.
Lamba JK; Crews K; Pounds S; Schuetz EG; Gresham J; Gandhi V; Plunkett W; Rubnitz J; Ribeiro R
J Pharmacol Exp Ther; 2007 Dec; 323(3):935-45. PubMed ID: 17855478
[TBL] [Abstract][Full Text] [Related]
53. T-lymphoblast-specific nucleoside kinase: characterization and comparison with deoxycytidine kinase.
Yamada Y; Goto H; Ogasawara N
Int J Biochem; 1985; 17(3):425-8. PubMed ID: 2989022
[TBL] [Abstract][Full Text] [Related]
54. Positive regulation of deoxycytidine kinase activity by phosphorylation of Ser-74 in B-cell chronic lymphocytic leukaemia lymphocytes.
Smal C; Van Den Neste E; Maerevoet M; Poiré X; Théate I; Bontemps F
Cancer Lett; 2007 Aug; 253(1):68-73. PubMed ID: 17350163
[TBL] [Abstract][Full Text] [Related]
55. Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress.
Austin WR; Armijo AL; Campbell DO; Singh AS; Hsieh T; Nathanson D; Herschman HR; Phelps ME; Witte ON; Czernin J; Radu CG
J Exp Med; 2012 Nov; 209(12):2215-28. PubMed ID: 23148236
[TBL] [Abstract][Full Text] [Related]
56. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
57. A comparison of the enantioselectivities of human deoxycytidine kinase and human cytidine deaminase.
Shafiee M; Griffon JF; Gosselin G; Cambi A; Vincenzetti S; Vita A; Eriksson S; Imbach JL; Maury G
Biochem Pharmacol; 1998 Nov; 56(9):1237-42. PubMed ID: 9802336
[TBL] [Abstract][Full Text] [Related]
58. Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides.
Sabini E; Hazra S; Konrad M; Lavie A
J Med Chem; 2007 Jun; 50(13):3004-14. PubMed ID: 17530837
[TBL] [Abstract][Full Text] [Related]
59. Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase.
Jordan PC; Stevens SK; Tam Y; Pemberton RP; Chaudhuri S; Stoycheva AD; Dyatkina N; Wang G; Symons JA; Deval J; Beigelman L
ACS Chem Biol; 2017 Jan; 12(1):83-91. PubMed ID: 28103684
[TBL] [Abstract][Full Text] [Related]
60. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
